Talcum Powder Cancer Lawsuit

DOJ Starts Criminal Investigation Into Corporate Officers Who Misled About Talc Safety

Federal investigators are looking into whether executives hid or changed safety data on talc products that were linked to cancer claims

Monday, September 1, 2025 - The U.S. Department of Justice is looking into whether corporate leaders willfully lied about talcum powder safety, especially since more and more lawsuits are linking talc to cancer. The investigation is looking into whether high-level executives lied about things like keeping internal research secret, not telling people about the hazards of asbestos contamination, or downplaying scientific results that showed possible harm. For years, thousands of women and their families have sued, saying that they got cancer after using talc-based products for many years, especially in the vaginal area. Many of these lawsuits say that the companies that made the talcum powder didn't include a clear warning about talcum powder cancer risk on the container or in ads, even though they supposedly knew about the hazards. If federal investigators find that people are intentionally trying to hide or change data, what was once thought to be a civil liability concern could become a criminal one.

The U.S. Food and Drug Administration (FDA) said that tests have found amounts of asbestos in some cosmetic talc products. Asbestos is a proven carcinogen with no safe level of exposure. This fact has made both regulators and consumers angry. The current DOJ investigation is looking into whether internal communications and scientific findings were changed, hidden, or misrepresented to investors, regulators, or the public. Legal experts say that the criminal investigation adds a new layer to a debate that has mostly taken place in civil courts over the past ten years. It also makes things riskier for businesses and their leaders, who might now be charged with a crime if they are found guilty of fraud, obstruction, or conspiracy. The move shows that federal agencies are being increasingly strict about holding businesses responsible for product safety, especially when a lot of people are exposed to the product and there is a chance of health problems.

The DOJ's involvement could change how consumer product safety is checked and enforced in the future. Criminal investigations, as opposed to civil lawsuits, frequently lead to more thorough examinations, possible incarceration, and extensive institutional improvements. If charges are brought and convictions are secured, it might scare the whole business and make people more likely to report problems and do more thorough safety checks. Regulatory agencies may be more likely to act quickly, and businesses may rethink how they handle scientific findings within their own organizations. On the other hand, consumers may profit from better product labels and stronger legal protections. In the end, this case could change what it means for companies to be responsible for public health. It could send a message that lying to the public about product safety is not only wrong, but also a crime.

This kind of legal action from the federal government may also make it easier for people who work for companies to come forward about product safety issues in the future. When there is a real possibility of being arrested, employees and executives may think twice about choosing to keep quiet or deny something instead of being open about it.

Information provided by TalcumPowderCancerLawsuit.com, a website devoted to providing news about talcum powder ovarian cancer lawsuits, as well as medical research and findings.

More Recent Talcum Powder Ovarian Cancer Lawsuit News:

View all Talcum Powder Cancer Lawsuit News

No-Cost, No-Obligation Baby Powder Lawsuit Case Review for Persons or Families of Persons Who Developed Ovarian Cancer After a History of Perineal Baby Powder Use

OnderLaw, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The Onder Law Firm has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others. The firm has represented thousands of persons in these and other products liability litigation, including DePuy hip replacement systems, which settled for $2.5 billion and Pradaxa internal bleeding, which settled for $650 million. The Onder Law Firm won over $300 million in four talcum powder ovarian cancer lawsuits in St. Louis to date and other law firms throughout the nation often seek its experience and expertise on complex litigation.


Privacy Notice: This site uses cookies for advertising, analytics and to improve our site services. By continuing to use our site, you agree to our use of cookies. For more information, see our cookie and privacy policy.